Monthly Communication Report

Corporation:	AbbVie Corporation
Associated registration:	957373-15270-44
Communication date:	2025-12-01
Posted date:	2026-01-15

Designated Public Office Holders who participated in the communication:	Greg Orencsak, Deputy Minister Deputy Minister's Office, Health Canada (HC) Sarah Lawley, Assistant Deputy Minister Health Policy Branch, Health Canada (HC) Pamela Aung-Thin, Assistant Deputy Minister Health Products and Food Branch, Health Canada (HC)
List of Details Subject matter Detail Health, Industry, Intellectual Property, International Trade Communication regarding free trade agreements as they relate to the biopharmaceutical industry. Health, Research and Development Communications regarding Health Canada's Regulatory Innovation Agenda regarding proposed regulatory amendments and guidelines to enable agile licensing of drugs and medical devices. Health Communications regarding opportunities to speed patient access to live-saving medicines on publicly-funded drug formularies in Canada by reducing red tape. Health, Research and Development Communications with Health Canada regarding modernization of clinical trials regulations, including diversity and inclusivity of clinical trials.
Responsible Officer who filed this communication report:	RAMI FAYED
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.